Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023–2024
Emerging Infectious Diseases · 2025-03 · 31 (3)
DOI: 10.3201/eid3103.240594 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2025-03. Verfasst von Kaiming Bi und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19, Hospitalization, Respiratory Syncytial Virus Infections, Influenza, Human. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCIRD CDC HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Förderung
- NIAID NIH HHS
- NCIRD CDC HHS
Zitieren
APA
Bi, K., Bandekar, S. R., Bouchnita, A., Fox, S. J., & Meyers, L. A. (2025). Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023–2024. Emerging Infectious Diseases, 31(3). https://doi.org/10.3201/eid3103.240594
Vancouver
Bi K, Bandekar SR, Bouchnita A, Fox SJ, Meyers LA. Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023–2024. Emerging Infectious Diseases. 2025;31(3). doi:10.3201/eid3103.240594
BibTeX
@article{Bi2025,
author = {Bi, Kaiming and Bandekar, Shraddha Ramdas and Bouchnita, Anass and Fox, Spencer J and Meyers, Lauren Ancel},
title = {Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023–2024},
journal = {Emerging Infectious Diseases},
year = {2025},
volume = {31},
number = {3},
doi = {10.3201/eid3103.240594}
}
EUVIMED